Overview
Alpen Pharma Polska takes part in medical events, including a workshop in Tbilisi and a symposium at the ISIAN & IRS 2024 congress. It also participates in pediatric and otolaryngology conferences.
Financials
Revenue history (in k)
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 33 days for 2025).
- 202517/08/2026
- 202428/07/2025
- 202328/06/2024
- 202213/06/2023
- 202103/06/2022
- 202031/08/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
25th International Workshop Alpen Pharma in Tbilisi
Dom O nas Alpen Pharma na świecie Alpen Pharma w Polsce Misja i wartości firmy Nadzór nad bezpieczeństwem farmakoterapii Produkty Zdrowie Piękno Alfabetycznie Tematycznie Media Aktualności Informacje prasowe Biblioteka dla mediów Partnerstwo Kariera Kontakt Alpen Pharma Polska Sp. z o.o. © Copyright 2026. Wszelkie prawa zastrzeżone.
Active Flora BABY+10 ml - new product by Alpen Pharma
Alpikol lozenges - dietary supplement by Alpen Pharma
Alpikol, immunity syrup - new product by Alpen Pharma
Apicold® 1+ marshmallow root syrup with honey added
Apicold® oral spray - new product in Alpen Pharma's offer
Industry
Offer
- Dietary supplements
- Probiotics
- Throat lozenges
- Immune support syrups
- Oral sprays
Website technology
- Website
- WordPress
- Drupal
- Analytics and marketing
- Google Tag Manager
Trademarks
Alpen Pharma Polska currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2016.
| Mark | Protected until | |
|---|---|---|
| Active Flora(word) | – |
Authorized Representatives
Manner of representation
Each member of the management board independently and an independent commercial proxy independently is authorized to submit declarations of will on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 25,355 | $684,900.05 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2016-05-01.
72 1020 1055 0000 9602 0363 9853- 57 1020 1055 0000 9202 0463 8740
- 77 1020 1055 0000 9402 0363 9861
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| PUBE Globalsp. z o.o. | $1,777,827.09 | pubeglobal.com | ||
| Totis Pharmasp. z o.o. | $1,777,307.47 | totispharma.com | ||
| Tricopat Globalsp. z o.o. | $1,772,824.41 | tricopatglobal.com | ||
| New Nordic Healthbrands Polskasp. z o.o. | $1,677,813.61 | newnordic.pl | ||
| Farmedicasp. z o.o. | $1,689,796.86 | farmedica.pl | ||
| Phytopur Biosp. z o.o. | $1,672,156.55 | phytopurbio.pl | ||
| DEEP Pharmasp. z o.o. | $1,664,192.79 | deeppharma.pl | ||
| Dermaprofilsp. z o.o. | $1,431,262.08 | dermaprofil.pl | ||
| Atradis Polskasp. z o.o. | $1,284,064.17 | atradis.pl | ||
| Eickemeyer - Veterinary Technology for Lifesp. z o.o. | $1,238,702.38 | eickemeyer.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-09-05 | Share capital increase (524,000.00 PLN → 2,535,500.00 PLN) | |
| 2020-05-05 | Address change (Al. Aleje Jerozolimskie 151/1, 02-326, Warszawa → Al. Aleje Jerozolimskie 100, 00-807, Warszawa) | |
| 2017-01-13 | PKD change (Removed: 9 codes; Added: 9 codes) | |
| 2016-03-14 | Entered in the register |
FAQ
Last updated: 2026-08-21